Searched for
DRY AMD
Prices of Nvidia's B300 server at $1 million in China on US curbsNvidia's B300 servers have skyrocketed in price to around one million dollars each in China, fueled by an insatiable appetite for AI comput...- Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPEEyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment ...
- Eyestem’s Eyecyte-RPE trial shows vision rescue for geographic atrophy patientsEyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy Innovation Summit in ...
- Eyestem completes first set of patient injections for Dry AMD treatmentEyestem Research has completed the first set of patient injections for its RPE suspension therapy aimed at treating Dry age-related macular...
- Eyestem to begin human trials for its pioneering Dry AMD treatmentDry AMD, a leading cause of vision loss in the ageing population of people over 50, has long been a challenge due to the limited availabili...
- Advancing stem cell therapy: The regulatory process to get to clinical trialsAdvancements in new drug and stem cell therapy can transform the treatment of many diseases, but development is complicated, takes years an...
- Eyestem partners with RetinAI for treatment of geographic atrophy with AI techGeographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.
- Eyestem files for IND approval for its product to treat geographic atrophyEyestem Research has announced the submission of IND application to CDSCO to start first in-human trials of Eyecyte-RPE™for subjects.
- Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisorsEyestem has appointed Ravi Achar as Head- North America Strategy and also engaged Stradling Yocca Carlson & Rauth as its US law firm.
- Why can't Dame Judi Dench read her scripts anymore? Read to knowDame Judi Dench, an Oscar-winning actor, can no longer read scripts because of macular degeneration, an eye condition. It has been at least...
- Eyestem raises Series A round from Biological E, Alkem and othersThe investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.
- Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & NatcoExisting investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Cror...
- Eyestem has a visionary approach to make cell therapy affordable in IndiaCell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...
- Swachh Amrit Mahotsav: Chhattisgarh wins in cleanest state category third year in a rowExplaining the efforts that went into the win, the public relations department official said Chhattisgarh was the only state in the country...
- Exploration results showing deposits of uranium, lithium, helium and Rare Earth Elements in Arunachal PradeshIt was also decided in the meeting that the state government, through its department of Geology and Mining, would collaborate with Atomic M...
- Telangana sitting on atomic time bomb as high levels of uranium concentration found in groundwaterThe frighteningly high uranium concentration in groundwater samples were found by the AMD.
- Surgeons, a step closer to curing blindnessSurgeons in the UK have carried out a pioneering human embryonic stem cell operation in their efforts to find a cure for age-related blindn...
- SpiceJet takes delivery of another Airbus planeNo-frills carrier SpiceJet, which is looking to expand its fleet, has taken delivery of another Airbus plane on wet lease basis.
- Signs that could indicate a loss of visionHere's why ignoring that black spot floating in front of your eye could mean loss of vision.
- Sun & Intrexon JV for ocular diseasesThe joint venture will leverage Sun Pharma's global capabilities and experience in developing and manufacturing complex dosage forms and sp...
Load More
